{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:07:28Z","timestamp":1785852448613,"version":"3.56.0"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1097\/01.fjc.0000157441.95354.d6","type":"journal-article","created":{"date-parts":[[2005,3,16]],"date-time":"2005-03-16T04:01:01Z","timestamp":1110945661000},"page":"348-353","source":"Crossref","is-referenced-by-count":8,"title":["Ebelactone B, an Inhibitor of Extracellular Cathepsin A-Type Enzyme, Suppresses Platelet Aggregation Ex Vivo in Renovascular Hypertensive Rats"],"prefix":"10.1097","volume":"45","author":[{"given":"Halina","family":"Ostrowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Kalinowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Chabielska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Stankiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamil","family":"Kruszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wlodzimierz","family":"Buczko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210208","first-page":"419","article-title":"Prothrombotic effects of angiotensin.","volume":"45","author":"Brown","year":"2000","journal-title":"Adv Intern Med"},{"key":"R2-12-20210208","doi-asserted-by":"crossref","first-page":"205S","DOI":"10.1016\/S0895-7061(99)00103-X","article-title":"The renin-angiotensin-aldosterone system: a specific target for hypertension management.","volume":"12","author":"Weir","year":"1999","journal-title":"Am J Hypertens"},{"key":"R3-12-20210208","first-page":"1","article-title":"Bioregulation of kinins: kallikreins, kininogens, and kininases.","volume":"44","author":"Bhoola","year":"1992","journal-title":"Pharmacol Rev"},{"key":"R4-12-20210208","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S1357-2725(02)00262-5","article-title":"The renin-angiotensin and the kallikrein-kinin systems.","volume":"35","author":"Campbell","year":"2003","journal-title":"Int J Biochem Cell Biol"},{"key":"R5-12-20210208","doi-asserted-by":"crossref","first-page":"8619","DOI":"10.1016\/S0021-9258(18)34171-1","article-title":"Rapid conversion of angiotensin I to angiotensin II by neutrophil and mast cell proteinases.","volume":"257","author":"Reilly","year":"1982","journal-title":"J Biol Chem"},{"key":"R6-12-20210208","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1042\/bj2660055","article-title":"Cathepsin G binding to human platelets. Evidence for a specific receptor.","volume":"266","author":"Selak","year":"1990","journal-title":"Biochem J"},{"key":"R7-12-20210208","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1055\/s-0038-1642680","article-title":"Platelet activation by polymorphonuclear leukocytes: Role of cathepsin G and P-selectin.","volume":"74","author":"Cerletti","year":"1995","journal-title":"Thromb Haemost"},{"key":"R9-12-20210208","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1165\/ajrcmb.13.2.7626287","article-title":"Plasma membrane-bound and lysosomal peptidases in human alveolar macrophages.","volume":"13","author":"Jackman","year":"1995","journal-title":"Am J Respir Cell Mol Biol"},{"key":"R10-12-20210208","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1600-065X.1998.tb01577.x","article-title":"Cellular carboxypeptidases.","volume":"161","author":"Skidgel","year":"1998","journal-title":"Immunol Rev"},{"key":"R11-12-20210208","first-page":"181","article-title":"Degradation of bradykinin in human urine by carboxypeptidase Y-like exopeptidase and neutral endopeptidase and their inhibition by ebelactone B and phosphoramidon.","volume":"17","author":"Saito","year":"1995","journal-title":"Int J Tissue React"},{"key":"R12-12-20210208","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1161\/01.HYP.0000017283.67962.02","article-title":"Angiotensin 1-9 and 1-7 release in human heart. Role of cathepsin A.","volume":"39","author":"Jackman","year":"2002","journal-title":"Hypertension"},{"key":"R13-12-20210208","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1006\/jmcc.2002.2080","article-title":"Products of angiotensin I hydrolysis by human cardiac enzymes potentiate bradykinin.","volume":"34","author":"Erdos","year":"2002","journal-title":"J Mol Cell Cardiol"},{"key":"R14-12-20210208","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1055\/s-0038-1646066","article-title":"Guidelines for the use of animal in biomedical research.","volume":"58","author":"Giles","year":"1987","journal-title":"Thromb Haemost"},{"key":"R15-12-20210208","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1161\/01.HYP.3.3.285","article-title":"Bilateral renal function responses to converting enzyme inhibitor (SQ 20,881) in two-kidney, one clip Goldblatt hypertensive rats.","volume":"3","author":"Huang","year":"1981","journal-title":"Hypertension"},{"key":"R16-12-20210208","first-page":"198","article-title":"A low cost tail-cuff method for the estimation of mean arterial pressure in unconscious rats.","volume":"40","author":"Zatz","year":"1990","journal-title":"Lab Anim Sci"},{"key":"R17-12-20210208","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/1056-8719(96)00006-8","article-title":"A highly reproducible model of arterial thrombosis in rats.","volume":"35","author":"Guarini","year":"1996","journal-title":"J Pharmacol Toxicol Methods"},{"key":"R18-12-20210208","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1055\/s-0037-1615007","article-title":"Comparative studies of an orally-active factor Xa inhibitor, YM-60828, with other antithrombotic agents in a rat model of arterial thrombosis.","volume":"79","author":"Kawasaki","year":"1998","journal-title":"Thromb Haemost"},{"key":"R19-12-20210208","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1055\/s-0038-1651642","article-title":"Effects of antithrombotic drugs in rat model of aspirin-insensitive arterial thrombosis.","volume":"69","author":"Schumacher","year":"1993","journal-title":"Thromb Haemost"},{"key":"R20-12-20210208","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(95)00320-K","article-title":"Ebelactone B, an inhibitor of urinary carboxypeptidase Y-like kininase, prevents the development of deoxycorticosterone acetate-salt hypertension in rats.","volume":"284","author":"Majima","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"R21-12-20210208","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.2042-7158.1985.tb05026.x","article-title":"The effect of 6-oxo-PGE1 on human platelet aggregation in whole blood in vitro.","volume":"37","author":"Wilsoncroft","year":"1985","journal-title":"J Pharm Pharmacol"},{"key":"R22-12-20210208","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1006\/bbrc.1997.6434","article-title":"Lactacystin, a specific inhibitor of the proteasome, inhibits human platelet lysosomal cathepsin A-like enzyme.","volume":"234","author":"Ostrowska","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"R23-12-20210208","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1016\/S0021-9258(18)94488-1","article-title":"Amino acid analysis: aqueous dimethyl sulfoxide as solvent for ninhydrin reaction.","volume":"243","author":"Moore","year":"1968","journal-title":"J Biol Chem"},{"key":"R24-12-20210208","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"key":"R25-12-20210208","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1053\/XV.2000.5490","article-title":"Inhibition of arterial thrombogenesis by quinapril but not losartan.","volume":"5","author":"Bavry","year":"2000","journal-title":"Cardiovasc Pharmacol Ther"},{"key":"R26-12-20210208","first-page":"150","article-title":"Effects of ebelactone B on cathepsin A activity in intact platelets and on platelet activation.","volume":"48","author":"Ostrowska","year":"2003","journal-title":"Roczniki Akademii Medycznej w Blalymstoku"},{"key":"R27-12-20210208","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/00005344-199710000-00009","article-title":"ACE inhibitor effects on platelet function in stages I-II hypertension.","volume":"30","author":"Moser","year":"1997","journal-title":"J Cardiovasc Pharmacol"},{"key":"R28-12-20210208","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/ndt\/16.suppl_1.45","article-title":"Angiotensin II AT (1) receptor antagonists and platelet activation.","volume":"16","author":"Lopez-Farre","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"R29-12-20210208","first-page":"251","article-title":"The antithrombotic effect of captopril and losartan on experimental arterial thrombosis in rats.","volume":"49","author":"Chabielska","year":"1998","journal-title":"J Physiol Pharmacol"},{"key":"R30-12-20210208","first-page":"99","article-title":"Antithrombotic activity of losartan in two kidney, one clip hypertensive rats: a study on the mechanism of action.","volume":"50","author":"Chabielska","year":"1999","journal-title":"J Physiol Pharmacol"},{"key":"R31-12-20210208","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0165-6147(00)89033-1","article-title":"Approaches of the development of novel antihypertensive drugs: crucial role of the renal kallikrein-kinin system.","volume":"16","author":"Majima","year":"1995","journal-title":"Trends Pharmacol Sci"},{"key":"R32-12-20210208","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1046\/j.1440-1681.2000.03209.x","article-title":"Inhibition of kinin degradation on the luminal side of renal tubules reduces high blood pressure in deoxycorticosterone acetate salt-treated rats.","volume":"27","author":"Nakajima","year":"2000","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"R33-12-20210208","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0011-2240(86)90014-3","article-title":"Pharmacology of DMSO.","volume":"23","author":"Jacob","year":"1986","journal-title":"Cryobiology"},{"key":"R34-12-20210208","doi-asserted-by":"crossref","first-page":"11265","DOI":"10.1016\/S0021-9258(19)38586-2","article-title":"A peptidase in human platelets that deamidates tachykinins.","volume":"265","author":"Jackman","year":"1990","journal-title":"J Biol Chem"},{"key":"R35-12-20210208","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0049-3848(97)00084-4","article-title":"Cathepsin A activity in thrombin-activated human platelets.","volume":"86","author":"Ostrowska","year":"1997","journal-title":"Thromb Res"},{"key":"R36-12-20210208","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.4049\/jimmunol.153.10.4663","article-title":"Dominant chymotrypsin-like esterase activity in human lymphocyte granules is mediated by the serine carboxypeptidase called cathepsin A-like protective protein.","volume":"153","author":"Hanna","year":"1994","journal-title":"J Immunol"},{"key":"R37-12-20210208","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1161\/01.HYP.21.6.925","article-title":"Inactivation of endothelin-1 by an enzyme of the vascular endothelial cells.","volume":"21","author":"Jackman","year":"1993","journal-title":"Hypertension"},{"key":"R38-12-20210208","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/0006-291X(88)90257-4","article-title":"Conversion of angiotensin I to angiotensin II by cathepsin A isoenzymes of porcine kidney.","volume":"154","author":"Miller","year":"1988","journal-title":"Biochem Biophys Res Commun"},{"key":"R39-12-20210208","first-page":"471","article-title":"Biological roles of the non-integrin elastin\/laminin receptor.","volume":"377","author":"Hinek","year":"1996","journal-title":"Biol Chem"}],"container-title":["Journal of Cardiovascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.fjc.0000157441.95354.d6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:43:29Z","timestamp":1785851009000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00005344-200504000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1097\/01.fjc.0000157441.95354.d6","relation":{},"ISSN":["0160-2446"],"issn-type":[{"value":"0160-2446","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]}}}